InMode Ltd vs Twist Bioscience Corp — how do they compare? InMode Ltd trades at $15.16 (market cap $872.08M), while Twist Bioscience Corp trades at $125.49 (market cap $7.72B). The key difference: Twist Bioscience Corp is far larger — about 8.9× InMode Ltd's market cap, and Twist Bioscience Corp is trading nearer its 52-week high, InMode Ltd nearer its low. Which is the better fit depends on your goals.
| INMD | TWST | |
|---|---|---|
Market Cap | $872.08M | $7.72B |
Sector | Technology | Health |
52-Week High | $16.62 | $124.88 |
52-Week Low | $12.76 | $24.16 |
Enterprise Value | $375.42M | $7.65B |
Trailing returns across standard periods
InMode provides innovative medical technologies for minimally invasive surgical procedures. Its platforms use radiofrequency (RF) energy for aesthetic treatments like body contouring and skin tightening.
Read more on INMD →Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →